We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Cat.#: ACPP-1692
| Despition | GLUL Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1150 | Synthetic Nanodisc Human TRPV1 Protein (AC1150) | 10 µg | inquiry |
| ACPP-1753 | Human SPR Protein (AC1753) | 5 µg | inquiry |
| ACPP-1754 | Human VEGFC Protein, Sf9 (AC1754) | 2 µg | inquiry |
| ACPP-1761 | Human VCAM1 Protein (AC1761) | 2 µg | inquiry |
| ACPP-1808 | Human LIF Protein, Yeast (AC1808) | 5 µg | inquiry |
| ACPP-1133 | Synthetic Nanodisc Human OR52D1 Protein (AC1133) | 10 µg | inquiry |
| ACPP-1372 | Exendin 4 (AC1372) | 20 µg | inquiry |
| ACPP-1700 | Human SOX2 Protein, PolyR (AC1700) | 2 µg | inquiry |
| ACPP-1324 | Insulin Receptor Blocking Peptide (AC1324) | 250 µg | inquiry |
| ACPP-1626 | Human SHC1 Protein (AC1626) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.